New Delhi: Torrent Pharmaceuticals Ltd A growth of 56.45 per cent was recorded on Friday Consolidated Net Profit In 2014-15 it became Rs 449 crore. March Quarterride on Higher RevenueThe company posted a Consolidated Net Profit During the same period, a turnover of Rs 287 crore was done. Previous Financial Year, Torrent Pharmaceuticals said in one Regulatory Filings,
Consolidated Revenue Revenue from operations stood at Rs 2,745 crore in the fourth quarter of FY24 as against Rs 2,491 crore in the same quarter a year ago.
India Income 1,380 crore, which is 10 per cent higher, while brazil 372 crore, registering a growth of 17 per cent, and Germany The company said its net profit rose 11 per cent to Rs 280 crore during the quarter.
On the other hand, revenue from the US business declined by 6 per cent to Rs 262 crore.
Total expenditure Net profit in the quarter under review stood at Rs 2,145 crore, as against Rs 2,067 crore in the same period a year ago.
Torrent Pharma said its board has recommended a final dividend of Rs 6 per equity share of Rs 5 each, subject to the approval of shareholders.
Further, the board has also recommended seeking shareholder approval to raise up to Rs 5,000 crore by issuing equity shares including convertible bonds/debentures. Qualified Institutional Placement (QIP) and or any other mode.
Consolidated Net for the Financial Year Ended March 31, 2024 Benefit The company said that this year it was Rs 1,656 crore compared to Rs 1,245 crore last year.
Consolidated revenue from operations stood at Rs 10,728 crore in FY24, as against Rs 9,620 crore in FY23.
torrent-pharma-q4-results-net-profit-jumps-56-yoy-to-rs-449-crore-et-healthworld-pharma
